Related Experiment Video
Updated: Jun 21, 2026
12:04
The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
[Promising diagnostic model for systemic lupus erythematosus using proteomic fingerprint technology]
Zhuo-chun Huang1, Yun-ying Shi, Bei Cai
1Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
Summary
This study developed a diagnostic model for systemic lupus erythematosus (SLE) using proteomic fingerprint technology. The model shows high sensitivity and specificity for diagnosing SLE, offering a promising new tool.
Area of Science:
- Biomarker discovery
- Proteomics
- Immunology
Context:
- Systemic lupus erythematosus (SLE) diagnosis can be challenging.
- Current diagnostic methods may lack sensitivity or specificity.
- Proteomic fingerprint technology offers a novel approach to disease detection.
Purpose:
- To establish a diagnostic model for SLE using proteomic fingerprint technology.
- To evaluate the sensitivity and specificity of the developed model.
- To explore the potential of machine learning in SLE diagnostics.
Summary:
- A diagnostic model was created using proteomic fingerprint technology on serum samples from 232 individuals (SLE patients, other autoimmune diseases, healthy controls).
- A machine learning algorithm (decision boosting) identified differential protein peaks, creating a segregating pattern for SLE.
- The model achieved high diagnostic accuracy, with sensitivity and specificity rates of 91% and 92% respectively in initial testing, and 78% and 96% in a blinded set.
Impact:
- This proteomic fingerprint-based diagnostic model demonstrates significant potential for accurate and efficient SLE diagnosis.
- The findings suggest a promising new tool for clinical application in rheumatology.
- Further validation could lead to improved patient management and outcomes for SLE.
